Trial Profile
1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/tiotropium bromide (Primary) ; Salmeterol; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- Sponsors Boehringer Ingelheim; Boehringer Ingelheim Pharmaceuticals
- 21 Jan 2022 This trial has been completed in Finland(End Date: 21 Nov 2008), according to European Clinical Trials Database record.
- 19 Jan 2022 This trial has been completed in Greece (End Date: 21 Nov 2008), according to European Clinical Trials Database record.
- 30 Sep 2021 This trial has been completed in France (End Date: 21 Nov 2008), according to European Clinical Trials Database record.